Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 210 participants.
Also called NCT06453876
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 210 participants
- Registry
-
NCT06453876
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Recruiting
Technical summary
Registry record NCT06453876. Randomized; no masking; primary purpose treatment. Start 2026-06-17 (actual); primary completion 2028-06-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Percutaneous Embolectomy, Low Dose Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY II)
- Acronym
- STRATIFY-II
- Condition
- Pulmonary Embolism
- Intervention (Device)
- Ultrasound assisted Thrombolysis
- Intervention (Device)
- Percutaneous Embolectomy
- Intervention (Drug)
- Heparin
- Lead sponsor
- Jesper Kjaergaard
- Collaborator
- Zealand University Hospital
- Collaborator
- Copenhagen University Hospital at Herlev
- Collaborator
- Odense University Hospital
- Collaborator
- Aalborg University Hospital
Record details
- Record id
cardio:ct-nct06453876- Content hash
1bc2fe52b35dfbfc7ece1273c0f0272d218137b3cb6d69f0a69d2d59f89a137f